United States Authorizes Moderna As 2nd COVID-19 Vaccine

The United States authorized Moderna as the 2nd COVID-19 vaccine for emergency use. With death tolls climbing to 2,500 per day, the United States now has two vaccines approved. The first approval was for the COVID-19 vaccine by Pfizer and BioNTech which was already being given to frontliners in the US.

The two-dose Moderna vaccine is also based on mRNA or messenger ribonucleic acid technology which was studied to be 95% more effective than placebo.

Moderna proposed to ship 20 million vaccines in December and 80 million more for the first quarter of 2021 and 100 million by the second quarter.

Related Stories